U.S. Physical Therapy (NYSE:USPH) Price Target Raised to $95.00 at JPMorgan Chase & Co.

U.S. Physical Therapy (NYSE:USPHGet Free Report) had its price target upped by research analysts at JPMorgan Chase & Co. from $90.00 to $95.00 in a research report issued on Friday, Benzinga reports. The firm presently has an “overweight” rating on the stock. JPMorgan Chase & Co.‘s price objective points to a potential upside of 20.57% from the stock’s current price.

A number of other research firms have also commented on USPH. Barrington Research raised their price target on U.S. Physical Therapy from $90.00 to $98.00 and gave the stock an “outperform” rating in a report on Monday, August 10th. Weiss Ratings reiterated a “hold (c-)” rating on shares of U.S. Physical Therapy in a research note on Wednesday, August 26th. Citizens Jmp reissued a “market outperform” rating and set a $98.00 price objective on shares of U.S. Physical Therapy in a report on Wednesday, June 24th. Citigroup restated a “market outperform” rating on shares of U.S. Physical Therapy in a research note on Wednesday, August 19th. Finally, Zacks Research upgraded U.S. Physical Therapy from a “strong sell” rating to a “hold” rating in a research report on Wednesday, May 27th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $98.25.

Check Out Our Latest Analysis on USPH

U.S. Physical Therapy Stock Up 1.4%

Shares of NYSE:USPH traded up $1.08 during trading on Friday, reaching $78.79. 72,260 shares of the stock were exchanged, compared to its average volume of 208,788. U.S. Physical Therapy has a 1-year low of $58.19 and a 1-year high of $93.50. The stock has a fifty day moving average of $76.93 and a two-hundred day moving average of $73.12. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.27 and a quick ratio of 1.27. The firm has a market cap of $1.18 billion, a price-to-earnings ratio of 463.50, a price-to-earnings-growth ratio of 2.14 and a beta of 1.13.

U.S. Physical Therapy (NYSE:USPHGet Free Report) last issued its quarterly earnings data on Thursday, August 6th. The company reported $0.75 EPS for the quarter, missing the consensus estimate of $0.81 by ($0.06). The company had revenue of $214.06 million during the quarter, compared to analysts’ expectations of $211.36 million. U.S. Physical Therapy had a return on equity of 9.39% and a net margin of 3.97%.The business’s revenue for the quarter was up 8.5% compared to the same quarter last year. During the same period last year, the company earned $0.81 earnings per share. Research analysts anticipate that U.S. Physical Therapy will post 2.95 earnings per share for the current fiscal year.

Hedge Funds Weigh In On U.S. Physical Therapy

Hedge funds have recently modified their holdings of the company. Hantz Financial Services Inc. boosted its position in U.S. Physical Therapy by 56.4% during the 4th quarter. Hantz Financial Services Inc. now owns 366 shares of the company’s stock valued at $29,000 after acquiring an additional 132 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in shares of U.S. Physical Therapy in the 2nd quarter worth approximately $30,000. Integrated Wealth Concepts LLC bought a new position in shares of U.S. Physical Therapy in the 2nd quarter worth approximately $33,000. Advisory Services Network LLC purchased a new position in shares of U.S. Physical Therapy in the 3rd quarter valued at approximately $39,000. Finally, iSAM Funds UK Ltd purchased a new position in shares of U.S. Physical Therapy in the 3rd quarter valued at approximately $52,000.

U.S. Physical Therapy Company Profile

(Get Free Report)

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.

Read More

Analyst Recommendations for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.